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NTRODUCTION
Mucous membrane pemphigoid (MMP) is an
autoimmune, chronic inflammatory, subepithelial
blistering disease predominantly affecting mucous
membranes that is characterized  by linear
deposition of IgG, IgA, or C3 along the epithelial
basal membrane zone (BMZ).1 The oral mucosa is
almost always affected, followed by other mucosa
(ocular, nose, pharynx, larynx, esophagus, genitalia,
and anus) and rarely skin (5-10%).2 Gingiva is most
commonly involved, but oral involvement can also
be seen on palate, buccal mucosa, lips, posterior part
of pharynx, tongue, and floor of the mouth.3
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Abstract
Background: Mucous membrane pemphigoid (MMP) is a chronic, recurrent autoimmune blistering disease that primarily
affects mucous membranes, particularly in oral mucosa. Definite diagnosis of MMP based on anamnesis of disease history,
clinical features, and biopsy. The treatment of “low-risk” patients is topical or systemic corticosteroid. The treatment of “high-
risk” patient is systemic corticosteroid and/or systemic immunosuppressant (such as, dapsone or azathioprine). Purpose: The
purpose of this case report is to discuss clinical diagnosis and management of MMP. Case: This paper reports a case of 60 year-
old woman with chronic MMP. Case Management: Diagnosis of this case only based on anamnesis of disease history and
clinical features. The biopsy was not done because the patient refused it. The patient was treated with systemic corticosteroid
(prednisone). Result: After about 11 weeks of treatment the lesion showed improvement. Conclusion: Definite diagnosis of
MMP must be based on biopsy because clinical features of MMP resemble other vesicobullous diseases. MMP does not respond
well to the treatment due to its autoimmune nature but the therapy with systemic prednisone give a quite good result.
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The typical lesion is a small or large, clear–fluid
bulla, which breaks fairly rapidly leading to
pseudomembrane-covered, irregularly shaped
erosions.4 Lesions may present as intact bulla of
gingival or other mucosal surfaces, but more
frequently appear as nonspecific-appearing
erosions.5 The lesion usually recur, persist for along
time, and occasionally lead to atrophy or scarring.2
Precise data on the incidence of MMP are not
known; however, MMP is uncommon.3 MMP found
in 2-5 people per 100,000 population a year.6 Most
patient with MMP are elderly with a peak incidence
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at around 70 years.7 It appears to be twice as common
in women than men.6-7
Oral corticosteroids (prednisone or
prednisolone) are the cornerstone of therapy for
MMP. The initial dose varies from 30 to 60 mg/day
depending on the severity of the disease. It usually
takes 2-3 weeks to stop new bulla formation and for
old ones to heal. The dose is subsequently tapered
by 20% every 2-3 weeks until the dose of 10 mg/day
is reached. This dose is subsequently maintained on
alternate days and reduced by 5 mg every 2 weeks
until it is completely stopped.2
The purpose of this case report is to discuss MMP
in 63 year-old female patient that was diagnosed
clinically as well as the management of this disease.
CASE
On July 29, 2008, a 63 year-old female patient came
to Dental Department of Dr. Soetomo Hospital with
chief complain of painful wounds in her mouth.
According to anamnesis was revealed that since 2
months ago she had painful wounds resembled large
ulcers in her lips, cheeks, and tongue and never
healed. This wound made her difficult to eat and
speak. Patient then went to the dentist and referred
to Dental Department of Dr. Soetomo Hospital.
General condition of the patient was weak.
Medical history examination revealed that patient
had accident about 30 years ago and diagnosed with
contusion cerebri. Since that she often had vertigo
and used antivertigo (dimenhydrinate 50 mg, vitamin
B6 50 mg). Patient also had gastritis, stomach ulcer,
and occasionally melena. She had to use antacid and
antiulserative (omeprazol) everyday. In family
medical history there’s no known disorder.
Extra oral examination of lower lips showed long
brown crust size 5 x 2 mm (Figure 1, A). Intra oral
examination of lower labial mucosa showed irregular
bulla size 15 mm (Figure 1, A). Left buccal mucosa
showed long irregular bulla size 3-5 mm (Figure 1,
B). Right buccal mucosa showed irregular bulla size
12 mm (Figure 1, C). Left lower gingiva showed oval
bulla size 15 mm (Figure 1, B). Right lower gingiva
showed irregular bulla size 12 mm (Figure 1, C). Left
and right lateral tongue showed irregular bulla
(Figure 1, D and E).
CASE MANAGEMENT
At 1st visit, according to anamnesis and clinical
examination, clinical diagnosis this case was MMP
with pemphigus vulgaris as the differential
diagnosis. Patient was instructed to do complete
blood, SGPT, SGOT, and blood glucose examination,
but she already done it and the result was normal.
Patient was treated with prednisone 5 mg 3 times 4
tablets daily, hepatic protector once daily, and
benzydamin HCl oral rinse 3 times daily for 2 weeks.
At 2nd visit, 2 weeks later (August 12, 2008),
based on anamnesis it was known that the pain was
greatly reduced. Crust on lower lips was healed
(Figure 2, A). Lower labial mucosa showed irregular
bulla size 10 mm (Figure 2, A). Left buccal mucosa
showed irregular bulla size 3 x 10 mm (Figure 2, B).
Right buccal mucosa showed three long bullas size
Figure 1. July 29, 2008: bulla on lower labial mucosa, left and right buccal mucosa, left and right crust on lower lips.
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8 x 3 mm, 8 x 4 mm, and 8 x 2 mm (Figure 2, C). Left
lower gingiva showed irregular bulla size 12 x 4 mm
(Figure 2, B). Bulla on right lower gingiva was healed
(Figure 2, C). Left and right lateral tongue showed
irregular bulla (Figure 2, D and E). Patient was
treated with prednisone 5 mg 3 times 4 tablets daily,
hepatic protector once daily, and benzydamin HCl
oral rinse 3 times daily for 1 week.
At 3rd visit,  8 days later (August 20, 2008),
anamnesisrevealed that the pain was greatly
reduced. Lower labial mucosa showed round bulla
size 7 mm (Figure 3, A). Left buccal mucosa showed
irregular bulla size 3 x 8 mm (Figure 3, B). Right
buccal mucosa showed two irregular bullas size 12
x 10 mm and 10 x 2 mm (Figure 3, C). Left lower
gingiva showed long bulla size 12 x 3 mm (Figure
3, B). Right lower gingiva showed oval bulla size 5
x 3 mm (Figure 3, C). Left and right lateral tongue
showed irregular bulla (Figure 3, D and E). Patient
was treated with prednisone 5 mg 4 times 2 tablets
daily, hepatic protector once daily, and benzydamin
HCl oral rinse 3 times daily for 2 weeks.
At 4th visit, 2 weeks later (September 3, 2008),
according to anamnesis known that the pain was
still the same. Lower labial mucosa showed round
bulla size 4 mm (Figure 4, A). Left buccal mucosa
Figure 2. Visit II (August 12, 2008): bulla on lower labial mucosa, left and right buccal mucosa, left gingiva and left and right lateral
tongue showed improvement, crust on lower lips and bulla on right gingiva was healed.
Figure 3. Visit III (August 20, 2008): bulla on lower labial mucosa, left buccal mucosa, left gingiva and left and right lateral tongue
showed improvement, there’s no change of bulla on right buccal mucosa, and bulla on right gingiva reoccurred.
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Figure 4. Visit IV (September 3, 2008): bulla on lower labial mucosa labial and left buccal mucosa showed improvement, bulla on
right buccal mucosa, right lower buccal fold mucosa, and left and right lateral tongue became worse, and bulla on left
gingiva was healed.
showed oval bulla size 4 x 3 mm (Figure 4, B). Right
buccal mucosa showed oval bulla size 15 x 8 mm
(Figure 4, C). Right lower buccal fold mucosa showed
irregular bulla size 15 x 8 mm (Figure 4, C). Bulla on
left lower gingiva was healed (Figure 4, B). Left and
right lateral tongue showed irregular bulla (Figure
4, D and E). Patient was treated with prednisone 5
mg 3 times 2 tablets daily, hepatic protector once
daily, and benzydamin HCl oral rinse 3 times daily
for 2 weeks.
At 5th visit, from anamnesis 2 weeks later
(September 17, 2008), it was known that the pain was
still the same. Lower labial mucosa showed round
bulla size 2 mm (Figure 5, A). Left buccal mucosa
showed irregular bulla size 10 x 4 mm (Figure 5, B).
Right buccal mucosa showed irregular bulla size 10
x 8 mm (Figure 5, C). Bulla on left lower gingiva
was healed (Figure 5, B). Left and right lateral
tongue showed irregular bulla (Figure 5, D and E).
Patient was treated with prednisone 5 mg 4 times
daily, hepatic protector once daily, and benzydamin
HCl oral rinse 3 times daily for 2 weeks.
At 6 th visit,  4 weeks later (October 15, 2008),
anamnesis revealed that the mouth felt more
comfortable. Lower labial mucosa showed round
bulla size 1 mm (Figure 6, A). Left buccal mucosa
Figure 5. Visit V (September 17, 2008): there’s no change of bulla on lower labial mucosa, and bulla on left and right buccal mucosa,
left gingiva, right lower buccal fold mucosa and left and right lateral tongue showed improvement.
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showed oval bulla size 10 x 6 mm (Figure 6, B). Right
buccal mucosa showed two irregular bullas size 12
x 10 mm and 5 x 4 mm (Figure 6, C). Left lateral
tongue showed round bulla size 5 x 3 mm (Figure 6,
D). Right lateral tongue showed irregular bulla
(Figure 6, E). Patient was treated with prednisone 5
mg twice daily, hepatic protector once daily, and
benzydamin HCl oral rinse 3 times daily for 2 weeks.
DISCUSSION
The diagnosis of MMP is mainly based on history,
clinical examination and biopsy of the lesions.4
Patients with MMP typically present with persistent,
painful erosions on the mucous membranes.3 Oral
involvement is characterized by erythematous
patches, bullas, erosions, and ulcerations which can
be seen on palate, buccal mucosa, lips, posterior part
of pharynx, tongue, and floor of the mouth, and often
begin on gingiva, particularly near the teeth.1,3,7 Intact
bullas are rarely seen, but they may appear flaccid or
tense.3 When performing a biopsy, it had to include
vesicle and perilesional tissue not the erosion itself.4
Biopsy done for routine histopathology and direct
immunofluorescent study.5 Histologically there is loss
of attachment and separation of the full thickness of
epithelium from the connective tissue at BMZ.
Epithelium, though separated, remains for a time
intact and forms the roof of a bulla. The floor of bulla
is formed by connective tissue alone, infiltrated with
inflammatory cells.8 Direct immunofluorescent of
perilesional mucosa reveals linear deposisition of IgG,
C3, or less commonly IgA along BMZ. The use of salt
split skin or mucosal epithelium for indirect
immunofluorescence studies may increase the
sensitivity of this technique. Indirect
immunofluorescence utilizing salt split skin may
reveal binding to the roof and/or floor depending
upon the antigen targeted.9
In this case, diagnosis was based on history and
clinical examination. From anamnesis known that the
lesion was persistent and painful. Clinical
examination showed bullas on mucous membranes
of the mouth (gingiva, buccal mucosa, lips, and
tongue). Biopsy was not done because the patient
refused to it with the reason that this lesion was very
painful and she wanted to wait until the lesion was
healed.
Differential diagnosis of this case was pemphigus
vulgaris (PV). Many mucosal diseases appear very
similar; therefore, a complete diagnosis cannot be
made without utilizing several clinical tests such as
viewing the tissue histologically and using
immunofluorescence to confirm the diagnosis.10
Clinical feature of MMP can be differentiated with
PV. Classical lesion of PV is a thin-walled bulla on a
noninflamed base arising on otherwise normal
mucosa. More frequently, the clinician sees shallow
irregular ulcers because the bulla rapidly breaks. A
thin layer of epithelium peels away in an irregular
pattern, leaving a denuded base. The edges of the
lesion continue to extend peripherally over a period
of weeks until they involve large portions of the oral
mucosa.5 This case shown intact bullas on gingiva,
Figure 6. Visit VI (October 15, 2008): bulla on lower labial mucosa and left and right lateral tongue showed improvement, and bulla
on left and right buccal mucosa became worse.
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buccal mucosa, lips and tongue, and also there was
no erosion; therefore we diagnosis this case as MMP.
There is no gold standard therapy for MMP.11
MMP is a particularly difficult disease to treat.3-4,7 The
response of MMP to treatment modalities has been
variable.11 The primary aim of treatment is to stop
bulla formation, promote healing and prevent
scarring.3-4,7
Oral care includes appropriate dental hygiene,
referred for dental care, monitoring for candidiasis,
and topical anesthetics for pain.9 Candida infections
often result with the long-term use of corticosteroids
when patients are prone to these infections, so
nystatin and other antifungal treatment are often
needed as well. 10 Patients with MMP should avoid
foods high in acid (e.g., tomatoes and orange juice)
and foods with hard surfaces that may mechanically
traumatize oral mucosa (e.g., chips and nuts).3
Patients also should identify factor that may cause
exacerbations of the disease and avoid these
precipitants.7
In this case the patient was treated with
prednisone 60 mg/day as the initial dose for 3 weeks.
After that the dose was reduced gradually every 2
weeks, except for the dose of 20 mg/day because the
patient did not come for the next control. She came 4
weeks after her last control and said that she
continued the therapy with dose of 20 mg/day. The
patient instructed to eat soft foods and avoid acidic
foods. She also instructed to eat high calorie and high
vitamin food (e.g. fruit juice)
It can be concluded that diagnosis of MMP based
on history, clinical examination and biopsy of the
lesion. Definite diagnosis of MMP must be based on
biopsy because clinical features of MMP resemble
other vesicobullous diseases. MMP is a disorder that
extremely difficult to treat which does not respond
well to the treatment due to its autoimmune nature,
but the therapy with systemic prednisone give a quite
good result. The success of treatment also depends
on the ability to identify and avoid factors that may
cause exacerbations of the disease.
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